Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Boehringer Ingelheim
McKesson
Baxter
Fuji
Farmers Insurance
AstraZeneca
Federal Trade Commission
Cerilliant

Generated: May 27, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020316

« Back to Dashboard

NDA 020316 describes OXILAN-350, which is a drug marketed by Guerbet and is included in one NDA. Additional details are available on the OXILAN-350 profile page.

The generic ingredient in OXILAN-350 is ioxilan. There is one drug master file entry for this compound. Additional details are available on the ioxilan profile page.
Summary for 020316
Tradename:OXILAN-350
Applicant:Guerbet
Ingredient:ioxilan
Patents:0

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength62%
Approval Date:Dec 21, 1995TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength73%
Approval Date:Dec 21, 1995TE:RLD:No

Expired US Patents for NDA 020316

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Guerbet OXILAN-300 ioxilan INJECTABLE;INJECTION 020316-001 Dec 21, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Guerbet OXILAN-350 ioxilan INJECTABLE;INJECTION 020316-002 Dec 21, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
QuintilesIMS
Citi
AstraZeneca
Covington
Johnson and Johnson
Fish and Richardson
Medtronic
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.